Venus Remedies Limited has made a disclosure to the National Stock Exchange of India Ltd. and BSE Limited regarding the outcomes of director appointments/re-appointments that were placed before members at the 37th Annual General Meeting held on August 20, 2026. This disclosure is made in continuation of earlier disclosures made on May 26, 2026, regarding board approval for these appointments, and is pursuant to Regulation 30 of SEBI LODR.
The following four director-related matters were approved by members at the AGM:
1. Appointment of Mr. Saransh Chaudhary (DIN: 08752105) as an Executive Director (Whole-time Director) for a period of 5 consecutive years effective from May 26, 2026.
2. Appointment of Dr. Gurminder Singh Bedi (DIN: 11713102) as a Non-Executive Independent Director for a period of 5 consecutive years effective from May 26, 2026.
3. Re-appointment of Dr. (Mrs.) Manu Chaudhary (DIN: 00435834) as Joint Managing Director for a period of five years effective from October 1, 2026.
4. Re-appointment of Dr. (Mrs.) Savita Gupta (DIN: 0009450913) as Non-Executive Independent Director for a second term of five years effective from December 30, 2026.
The company stated that the voting results of these resolutions, along with the Scrutiniser's Report, will be submitted to the stock exchanges within prescribed timelines upon completion and consolidation of the voting process.
Director Profile Details (Annexure Information):
Dr. (Mrs.) Manu Chaudhary
- Role: Re-appointment as Joint Managing Director
- Effective Date: October 1, 2026
- Profile: Heads R&D and operations of the Company. M.Sc., M.Phil (Genetics) & Ph.D. with over three decades of experience in pharma. Designed and commissioned the company's world-class manufacturing facility at Baddi, India. Helped broaden product portfolio and enriched company's intellectual property.
- Date of Birth: December 26, 1969
- Relationship: Related to Mr. Pawan Chaudhary, Mr. Akshansh Chaudhary, Mr. Saransh Chaudhary, Mr. Peeyush Jain and Mr. Ashutosh Jain
- Shares Held: 15,68,000 shares
- Not debarred from appointment
Dr. (Mrs.) Savita Gupta
- Role: Re-appointment as Non-Executive Independent Director (2nd term)
- Effective Date: December 30, 2026
- Profile: B.Tech, Master of Engineering and Ph.D. with over 35 years of experience. Currently working as Professor at UIET, Panjab University, Chandigarh and previously served as director at UIET, Panjab University, Chandigarh.
- Date of Birth: August 18, 1973
- Relationship: Not related to any board member
- Shares Held: Nil
- Not debarred from appointment
Mr. Saransh Chaudhary
- Role: Appointment as Executive Director (Whole-time Director)
- Effective Date: May 26, 2026
- Profile: Alumnus of the University of Oxford, associated with Venus Remedies Limited for over 10 years. Currently serves as CEO of Venus Medicine Research Centre (VMRC) and President - Global Critical Care and Consumer Healthcare. Leads work in antimicrobial resistance, translational research, and consumer health. Authored over 18 peer-reviewed research papers, including establishment of India's first Organ-on-a-Chip laboratory.
- Date of Birth: June 18, 1995
- Relationship: Related to Mr. Pawan Chaudhary, Mrs. Manu Chaudhary, Mr. Akshansh Chaudhary, Mr. Peeyush Jain and Mr. Ashutosh Jain
- Shares Held: Nil
- Not debarred from appointment
Dr. Gurminder Singh Bedi
- Role: Appointment as Non-Executive Independent Director
- Effective Date: May 26, 2026
- Profile: Experienced Orthopaedic Surgeon with over 33 years of post-MS experience. Completed senior residency at Postgraduate Institute of Medical Education and Research. Academically distinguished with Gold Medal in MBBS and recipient of Pfizer Gold Medal for excellence in academics. Has presented papers at national conferences and authored several national and international publications in orthopaedics.
- Date of Birth: August 1, 1967
- Relationship: Not related to any board member
- Shares Held: Nil
- Not debarred from appointment
The disclosure confirms that all appointments comply with circulars issued by BSE Limited (ref. no. LIST/COMP/14/2018-19) and National Stock Exchange of India Limited (ref. no. NSE/CML/2018/24) dated June 20, 2018, with none of the appointees being debarred from holding director positions.
This intimation has been uploaded on the company's website at www.venusremedies.com.